Composition of Revenio’s Shareholders’ Nomination Board
Composition of Revenio’s Shareholders’ Nomination Board
Revenio Group Corporation | Stock Exchange Release | September 14, 2026 at 16:30:00 EEST
Revenio Group Corporation’s first Shareholders’ Nomination Board has been established. In accordance with the charter of the Nomination Board approved by the Annual General Meeting held on 12 May 2026, the Nomination Board consists of four members who, at the end of the trading day on 30 June 2026, represented the largest proportion of the votes conferred by all shares in the company and who wished to participate in the work of the Nomination Board. The Chair of the company’s Board of Directors serves as an expert member of the Nomination Board without membership or voting rights.
The composition of the Nomination Board is as follows:
- Casper Lorenzen, Investment Director, William Demant A/S (appointed by William Demant A/S)
- Charles Vilgrain, Managing Partner, Caravelle Capital SAS (appointed by Caravelle Capital SAS)
- Mira Mielonen, Senior Responsible Investment Specialist, Ilmarinen Mutual Pension Insurance Company (appointed by Ilmarinen Mutual Pension Insurance Company)
- Ville Kotipelto, Chief Portfolio Manager, Danske Invest Finnish Equity Fund (appointed by Danske Invest Finnish Equity Fund)
- Arne Boye Nielsen, Chair of the Board of Directors of Revenio Group Corporation
At its first meeting held on 14 September, 2026, the Nomination Board elected Casper Lorenzen as Chair from among its members.
The Shareholders’ Nomination Board of Revenio Group Corporation is a body established by the company’s shareholders and is responsible for preparing proposals concerning the election and remuneration of the members of the Board of Directors for the Annual General Meeting and, where necessary, for an Extraordinary General Meeting. The Nomination Board will submit its proposal to the company’s Board of Directors by 31 January 2027 at the latest. The Nomination Board is appointed annually. The largest shareholders are determined based on the shareholder register maintained by Euroclear Finland Ltd.
For further information, please contact
CEO Jouni Toijala
+358 50 484 0085
jouni.toijala@revenio.fi
Distribution
Nasdaq Helsinki Oy
Financial Supervisory Authority (FIN-FSA)
Main media
www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a leading turnkey solutions provider in the global eye care market. The group offers fast, user-friendly, and reliable tools for diagnosing a wide variety of eye diseases. Revenio’s solutions include e.g. tonometers, fundus imaging devices, optical coherence tomography (OCT), perimeters, multimodal devices, refraction systems, and software solutions under iCare and Visionix.
In May 2026, Revenio joined forces with Visionix, creating the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.